T1	CHEM 11 19	Combigan
#1	AnnotatorNotes T1	C1968041; Combigan; Organic Chemical · Pharmacologic Substance
T2	PROC 28 35	placebo
#2	AnnotatorNotes T2	C0032042; Placebos; Therapeutic or Preventive Procedure
T3	ANAT 58 64	ocular
#3	AnnotatorNotes T3	C0015392; Eye; Body Part, Organ, or Organ Component | C1280202; Entire eye; Body Part, Organ, or Organ Component
T4	DISO 78 98	hipertensos oculares
#4	AnnotatorNotes T4	C0028840; Ocular Hypertension; Disease or Syndrome
T5	ANAT 146 159	retrobulbares
#5	AnnotatorNotes T5	C0230065; Structure of retroorbital region; Body Location or Region | C1289304; Entire retroorbital region; Body Location or Region
T6	PROC 563 566	PIO
#6	AnnotatorNotes T6	C0430888; Intraocular pressure test; Diagnostic Procedure
T7	PROC 169 192	ecografía doppler color
#7	AnnotatorNotes T7	C0474781; Color doppler ultrasound; Diagnostic Procedure | C1869003; Colour doppler scan; Diagnostic Procedure
T8	DISO 207 227	hipertensos oculares
#8	AnnotatorNotes T8	C0028840; Ocular Hypertension; Disease or Syndrome
T9	DISO 229 232	HTO
#9	AnnotatorNotes T9	C0028840; Ocular Hypertension; Disease or Syndrome
T10	CHEM 253 261	Combigan
#10	AnnotatorNotes T10	C1968041; Combigan; Organic Chemical · Pharmacologic Substance
T11	PROC 270 277	placebo
#11	AnnotatorNotes T11	C0032042; Placebos; Therapeutic or Preventive Procedure
T12	PROC 364 399	estudio prospectivo y a doble ciego
#12	AnnotatorNotes T12	C0013072; Double-Blind Method; Research Activity + C0033522; Prospective Studies; Research Activity
T13	CHEM 436 444	Combigan
#13	AnnotatorNotes T13	C1968041; Combigan; Organic Chemical · Pharmacologic Substance
T14	PROC 458 481	tratamiento con placebo
#14	AnnotatorNotes T14	C3897898; Placebo Administration; Therapeutic or Preventive Procedure
T15	ANAT 634 637	ACR
#15	AnnotatorNotes T15	C0035301; Structure of central retinal artery; Body Part, Organ, or Organ Component | C1281307; Entire central retinal artery; Body Part, Organ, or Organ Component
T16	PROC 574 589	flujo sanguíneo
#16	AnnotatorNotes T16	C0005776; blood flow measurement; Diagnostic Procedure
T17	PROC 542 561	presión intraocular
#17	AnnotatorNotes T17	C0430888; Intraocular pressure test; Diagnostic Procedure
T18	ANAT 604 632	arteria central de la retina
#18	AnnotatorNotes T18	C0035301; Structure of central retinal artery; Body Part, Organ, or Organ Component | C1281307; Entire central retinal artery; Body Part, Organ, or Organ Component
T19	ANAT 644 660	arteria oftámica
#19	AnnotatorNotes T19	C0029078; Structure of ophthalmic artery; Body Part, Organ, or Organ Component | C1278937; Entire ophthalmic artery; Body Part, Organ, or Organ Component
T20	CHEM 711 719	Combigan
#20	AnnotatorNotes T20	C1968041; Combigan; Organic Chemical · Pharmacologic Substance
T21	PROC 904 912	tratados
#21	AnnotatorNotes T21	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T22	PROC 773 784	tratamiento
#22	AnnotatorNotes T22	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T23	PROC 867 874	placebo
#23	AnnotatorNotes T23	C0032042; Placebos; Therapeutic or Preventive Procedure
T24	PROC 877 888	tratamiento
#24	AnnotatorNotes T24	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T25	CHEM 917 925	Combigan
#25	AnnotatorNotes T25	C1968041; Combigan; Organic Chemical · Pharmacologic Substance
T26	CHEM 1086 1094	Combigan
#26	AnnotatorNotes T26	C1968041; Combigan; Organic Chemical · Pharmacologic Substance
T27	PROC 306 318	randomizados
#27	AnnotatorNotes T27	C0034656; Randomization; Research Activity
T28	PROC 1056 1064	tratados
#28	AnnotatorNotes T28	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T29	ANAT 48 57	sanguíneo
#29	AnnotatorNotes T29	C0005767; Blood; Body Substance
T30	ANAT 90 98	oculares
#30	AnnotatorNotes T30	C0015392; Eye; Body Part, Organ, or Organ Component | C1280202; Entire eye; Body Part, Organ, or Organ Component
T31	ANAT 219 227	oculares
#31	AnnotatorNotes T31	C0015392; Eye; Body Part, Organ, or Organ Component | C1280202; Entire eye; Body Part, Organ, or Organ Component
T32	PROC 237 248	tratamiento
#32	AnnotatorNotes T32	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T33	ANAT 1012 1015	ACR
#33	AnnotatorNotes T33	C0035301; Structure of central retinal artery; Body Part, Organ, or Organ Component | C1281307; Entire central retinal artery; Body Part, Organ, or Organ Component
T34	PROC 420 431	tratamiento
#34	AnnotatorNotes T34	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T35	ANAT 1180 1183	ACR
#35	AnnotatorNotes T35	C0035301; Structure of central retinal artery; Body Part, Organ, or Organ Component | C1281307; Entire central retinal artery; Body Part, Organ, or Organ Component
T36	ANAT 580 589	sanguíneo
#36	AnnotatorNotes T36	C0005767; Blood; Body Substance
T37	PROC 750 753	PIO
#37	AnnotatorNotes T37	C0430888; Intraocular pressure test; Diagnostic Procedure
T38	PROC 1225 1228	PIO
#38	AnnotatorNotes T38	C0430888; Intraocular pressure test; Diagnostic Procedure
T39	PHYS 42 57	flujo sanguíneo
#39	AnnotatorNotes T39	C0232338; Blood flow; Physiologic Function
T40	LIVB 68 77	pacientes
#40	AnnotatorNotes T40	C0030705; Patients; Patient or Disabled Group
T41	PHYS 132 145	hemodinámicos
#41	AnnotatorNotes T41	C0019010; Hemodynamics; Organ or Tissue Function
T43	LIVB 197 206	pacientes
#42	AnnotatorNotes T43	C0030705; Patients; Patient or Disabled Group
T44	LIVB 296 305	pacientes
#43	AnnotatorNotes T44	C0030705; Patients; Patient or Disabled Group
T45	Duration 505 512	3 meses
T48	Duration 685 696	los 3 meses
T50	Duration 759 769	tres meses
T51	PROC 800 824	parámetros hemodinámicos
#44	AnnotatorNotes T51	C4082936; Hemodynamic Monitoring; Health Care Activity
T52	LIVB 894 903	pacientes
#45	AnnotatorNotes T52	C0030705; Patients; Patient or Disabled Group
T54	LIVB 1046 1055	pacientes
#46	AnnotatorNotes T54	C0030705; Patients; Patient or Disabled Group
T42	Duration 1073 1081	3. meses
T46	Observation 1 7	Efecto
#47	AnnotatorNotes T46	C0235735; Unexpected therapeutic effect; Finding (?)
R1	Causes Arg1:T1 Arg2:T46	
R2	Causes Arg1:T2 Arg2:T46	
R3	Location_of Arg1:T29 Arg2:T39	
R4	Location_of Arg1:T3 Arg2:T39	
R5	Location_of Arg1:T30 Arg2:T4	
R6	Experiences Arg1:T40 Arg2:T4	
R7	Experiences Arg1:T40 Arg2:T46	
R8	Experiences Arg1:T40 Arg2:T1	
R9	Experiences Arg1:T40 Arg2:T2	
R10	Experiences Arg1:T40 Arg2:T39	
T47	Observation 124 159	cambios hemodinámicos retrobulbares
R12	Location_of Arg1:T5 Arg2:T47	
R14	Experiences Arg1:T43 Arg2:T47	
R15	Experiences Arg1:T43 Arg2:T7	
R16	Experiences Arg1:T43 Arg2:T8	
R17	Experiences Arg1:T43 Arg2:T9	
R18	Experiences Arg1:T43 Arg2:T32	
R19	Experiences Arg1:T43 Arg2:T11	
R20	Used_for Arg1:T10 Arg2:T32	
R21	Location_of Arg1:T31 Arg2:T8	
R22	Location_of Arg1:T31 Arg2:T9	
R23	Causes Arg1:T32 Arg2:T47	
R24	Causes Arg1:T11 Arg2:T47	
R25	Before Arg1:T27 Arg2:T34	
R26	Before Arg1:T27 Arg2:T14	
R27	Used_for Arg1:T13 Arg2:T34	
R28	Experiences Arg1:T44 Arg2:T34	
R29	Experiences Arg1:T44 Arg2:T14	
R30	Has_Duration_or_Interval Arg1:T13 Arg2:T45	
R31	Has_Duration_or_Interval Arg1:T14 Arg2:T45	
R32	Location_of Arg1:T36 Arg2:T16	
R33	Location_of Arg1:T18 Arg2:T16	
R34	Location_of Arg1:T15 Arg2:T16	
R35	Location_of Arg1:T19 Arg2:T16	
T49	CONC 661 680	en el momento basal
#48	AnnotatorNotes T49	C1442488; Baseline; Quantitative Concept (?)
R36	Overlap Arg1:T16 Arg2:T49	
R37	Overlap Arg1:T16 Arg2:T48	
R38	Overlap Arg1:T17 Arg2:T49	
R39	Overlap Arg1:T17 Arg2:T48	
R40	Overlap Arg1:T6 Arg2:T49	
R41	Overlap Arg1:T6 Arg2:T48	
T53	Observation 721 727;747 753	redujo la PIO
R42	Causes Arg1:T20 Arg2:T53	
R43	Used_for Arg1:T20 Arg2:T22	
R44	Has_Duration_or_Interval Arg1:T20 Arg2:T50	
R45	Before Arg1:T22 Arg2:T37	
T55	Quantifier_or_Qualifier 825 832	basales
R46	Has_Quantifier_or_Qualifier Arg1:T51 Arg2:T55	
#49	AnnotatorNotes T55	C1442488; Baseline; Quantitative Concept
R49	Experiences Arg1:T52 Arg2:T21	
R50	Used_for Arg1:T25 Arg2:T21	
T56	CONC 984 1015	índice de resistencia de la ACR
T57	CONC 1153 1183	índice de resistenciade la ACR
R51	Experiences Arg1:T54 Arg2:T28	
R52	Used_for Arg1:T26 Arg2:T28	
R53	Has_Duration_or_Interval Arg1:T26 Arg2:T42	
T58	Observation 1213 1228	descenso de PIO
T59	Spec_cue 1188 1194	podría
T60	CONC 1195 1205	explicarse
A1	Assertion T60 Speculated
R54	Speculation Arg1:T59 Arg2:T60	
R56	Causes Arg1:T26 Arg2:T58	
A2	Experiencer T52 Patient
A3	Experiencer T54 Patient
A4	Experiencer T40 Patient
A5	Experiencer T43 Patient
A6	Experiencer T44 Patient
R11	Has_Result_or_Value Arg1:T37 Arg2:T53	
R13	Has_Result_or_Value Arg1:T38 Arg2:T58	
